Hour24 News
Sophisticated and simple
-
New Phase 3 data positions Bezuclastinib as a potential new standard for KIT Exon 17/18 mutant GIST In a pivotal development for patients with advanced…
-
Introduction: A Global Day for Biomarker Science Oncomarkers Awareness Day, first observed on November 13, 2025, marks a milestone in the cancer care landscape. This…
-
Reframing Immunotherapy for Ovarian Cancer Immunotherapy has transformed cancer treatment by empowering the body’s own defender — the immune system — to recognize and destroy…
-
New Personalized Therapy Aims to Improve Tamoxifen Effectiveness Breast cancer remains the most common cancer among women worldwide, and hormone receptor–positive cancers account for a…
-
FDA Grants Fast Track Designation to EO2463 for Follicular Lymphoma The U.S. FDA has granted Fast Track designation to EO2463, a novel immunotherapy from Enterome,…
